» Articles » PMID: 26970968

MiR Clusters Target Cellular Functional Complexes by Defining Their Degree of Regulatory Freedom

Overview
Specialty Oncology
Date 2016 Mar 14
PMID 26970968
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Using the two paralog miR-23∼27∼24 clusters as an example and combining experimental and clinical data in a systematical approach to microRNA (miR) function and dysregulation, a complex picture of their roles in cancer is drawn. Various findings appear to be contradictory to a larger extent and cannot be fully explained by the classical regulatory network models and feedback loops that are mainly considered by one-to-one regulatory interactions of the involved molecules. Here, we propose an extended model of the regulatory role of miRs that, at least, supplements the usually considered single/oligo-target regulation of certain miRs. The cellular availability of the participating miR members in this model reflects an upper hierarchy level of intracellular and extracellular environmental influences, such as neighboring cells, soluble factors, hypoxia, chemotherapeutic drugs, and irradiation, among others. The novel model is based on the understanding of cellular functional complexes, such as for apoptosis, migration, and proliferation. These complexes consist of many regulatory components that can be targeted by miR cluster members to a different extent but may affect the functional complex in different ways. We propose that the final miR-related effect is a result of the possible degree of regulatory freedom provided by the miR effects on the whole functional complex structure. This degree of regulatory freedom defines to which extent the cellular functional complex can react in response to regulatory triggers, also understood as sensitization (more regulatory response options) or de-sensitization (less regulatory response options) of the system rather than single molecules.

Citing Articles

Integrated miRNA Profiling of Extracellular Vesicles from Uterine Aspirates, Malignant Ascites and Primary-Cultured Ascites Cells for Ovarian Cancer Screening.

Skryabin G, Komelkov A, Zhordania K, Bagrov D, Enikeev A, Galetsky S Pharmaceutics. 2024; 16(7).

PMID: 39065600 PMC: 11280431. DOI: 10.3390/pharmaceutics16070902.


Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis.

Moriondo G, Scioscia G, Soccio P, Tondo P, De Pace C, Sabato R Int J Mol Sci. 2022; 23(11).

PMID: 35682972 PMC: 9181687. DOI: 10.3390/ijms23116294.


Molecular Insights into miRNA-Driven Resistance to 5-Fluorouracil and Oxaliplatin Chemotherapy: miR-23b Modulates the Epithelial–Mesenchymal Transition of Colorectal Cancer Cells.

Gasiule S, Dreize N, Kaupinis A, Razanskas R, ciupas L, Stankevicius V J Clin Med. 2019; 8(12).

PMID: 31810268 PMC: 6947029. DOI: 10.3390/jcm8122115.


miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

Savardashtaki A, Shabaninejad Z, Movahedpour A, Sahebnasagh R, Mirzaei H, Hamblin M Epigenomics. 2019; 11(14):1627-1645.

PMID: 31702390 PMC: 7132634. DOI: 10.2217/epi-2019-0110.


Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients.

Nazarov P, Wienecke-Baldacchino A, Zinovyev A, Czerwinska U, Muller A, Nashan D BMC Med Genomics. 2019; 12(1):132.

PMID: 31533822 PMC: 6751789. DOI: 10.1186/s12920-019-0578-4.